Non-compartmental analysis employs assumption-free pharmacokinetic methods quantitating drug exposure without predefined models. Area under curve calculation integrates plasma concentration over time. Clearance determination = dose / AUC. Volume of distribution = dose / C?. Half-life estimation enables dosing interval prediction.
Regulatory submissions employ non-compartmental analysis supporting pharmacokinetics. Bioavailability comparison between formulations uses AUC ratios. Population heterogeneity assessment identifies covariate effects. Statistical sophistication improves parameter estimation. Post-approval pharmacokinetics employs non-compartmental methods.
General Biopharmaceutical Concepts
Non-Compartmental Analysis
Non-compartmental analysis is a model-independent pharmacokinetic approach used to estimate exposure, clearance and other pharmacokinetic parameters from concentration-time data.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →